Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data

BACKGROUND: Stratification of patients with severe asthma by blood eosinophil counts predicts responders to anti-interleukin (IL)-5 (mepolizumab and reslizumab) and anti-IL-5 receptor α (benralizumab) therapies. This study characterized patients with severe asthma who could qualify for these biologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Husereau, Don, Goodfield, Jason, Leigh, Richard, Borrelli, Richard, Cloutier, Michel, Gendron, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913870/
https://www.ncbi.nlm.nih.gov/pubmed/29713354
http://dx.doi.org/10.1186/s13223-018-0241-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913870/
https://www.ncbi.nlm.nih.gov/pubmed/29713354
http://dx.doi.org/10.1186/s13223-018-0241-1

Ejemplares similares